AKT1 and cancer: It is relevant that 9 tumors have a deletion of two genes previously related to cancer progression such as PLEKHO1 [26] a negative regulator of the mitogenic PI3K/AKT signaling pathway and APH1A [27] which loss of expression has been associated to poor survival in triple negative breast cancer patients [27].